Aust Matthias, Pototschnig Hanno, Jamchi Sarina, Busch Kay-Hendrik
Plastic Surgery, Waldkrankenhaus Bonn, Bonn, DEU.
Regenerative Medicine, Munich Medical Esthetic, Bonn, DEU.
Cureus. 2018 Jul 18;10(7):e2999. doi: 10.7759/cureus.2999.
Background Treatment of the lower eyelid region to rejuvenate the skin or treat actinic elastosis often proves difficult. Established treatment options, such as hyaluronic acid injections, botulinum toxin injections, microneedling, skin resurfacing (microdermabrasion, chemical peel (exfoliation), laser treatment), as well as blepharoplasties and autologous fat transfers, can be associated with significant risks and increased patient burden. Furthermore, they may not be effective for treating the signs of skin aging or actinic elastosis, including dark rings under the eyes, a lack of volume and cutis laxa. A minimally invasive treatment approach which visibly improves the above-mentioned conditions and which involves minimal risk and patient burden would be a desirable alternative. Materials & methods Twenty patients were treated a total of three times at monthly intervals with PRP (platelet-rich plasma). The patients were examined on the days of treatment and one month after the third injection. The PRP was obtained directly prior to treatment using the Arthrex ACP double syringe at the point of care. The injections (2 ml PRP per side) were administered laterally using 27 G 38 mm cannulas. Accurate photographic documentation and skin elasticity measurements using a cutometer were performed to objectify the subjective assessments from the patient and practitioner questionnaires. Results A progressive improvement in the esthetic outcome and a high level of patient satisfaction were determined. The cutometer measurements showed a statistically significant higher level of skin firmness (due to increased collagen production) and a statistically significant increase in skin elasticity (thanks to increased elastin production). Other than the anticipated visible swelling directly after the PRP injection, no other undesirable side effects or complications occurred. The typical burning sensation during the injection had not been reported. Conclusion The results indicate that a series of PRP injections in the lower eyelid region is a safe, efficient, virtually pain-free, simple and rapid treatment option for an area with otherwise limited treatment alternatives.
背景 下眼睑区域的皮肤年轻化或治疗光化性弹性组织变性的治疗往往颇具难度。已有的治疗方法,如透明质酸注射、肉毒杆菌毒素注射、微针治疗、皮肤磨削术(微晶磨皮、化学剥脱(去角质)、激光治疗),以及眼睑成形术和自体脂肪移植,可能会带来重大风险并增加患者负担。此外,它们可能对治疗皮肤老化迹象或光化性弹性组织变性无效,包括黑眼圈、容积缺失和皮肤松弛。一种能显著改善上述状况且风险和患者负担极小的微创治疗方法将是理想的选择。
材料与方法 20名患者每隔一个月接受共三次富血小板血浆(PRP)治疗。在治疗当天以及第三次注射后一个月对患者进行检查。PRP在治疗前使用Arthrex ACP双注射器在护理点直接获取。使用27G 38mm套管针在外侧注射(每侧2ml PRP)。进行精确的照片记录,并使用皮肤弹性测量仪测量皮肤弹性,以客观化患者和医生问卷中的主观评估。
结果 确定了美学效果的逐步改善和患者的高度满意度。皮肤弹性测量仪测量显示,皮肤紧致度有统计学意义的提高(由于胶原蛋白生成增加),皮肤弹性有统计学意义的增加(由于弹性蛋白生成增加)。除了PRP注射后直接出现的预期可见肿胀外,未发生其他不良副作用或并发症。未报告注射期间典型的烧灼感。
结论 结果表明,在下眼睑区域进行一系列PRP注射是一种安全、有效、几乎无痛、简单且快速的治疗选择,而该区域其他治疗选择有限。